How can regulatory lapses in the pharmaceutical sector impact public health and international trust in Indian medicines?
The news about killer cough syrup highlights concerns about drug safety. I want to understand the broader implications of such incidents for both health outcomes and India's reputation in the global pharmaceutical market.